<DOC>
	<DOCNO>NCT01865773</DOCNO>
	<brief_summary>A major limitation standard hemodialysis clear plasma interleukin-6 ( IL-6 ) p-cresol , two uremic toxin responsible high cardiovascular risk end stage renal disease ( ESRD ) . In present study , evaluate whether compound remove HFR-Supra , double-chamber hemodiafiltration system ultrafiltrate ( UF ) return patient regeneration resin cartridge . We select 8 inflamed chronic hemodialysis ( HD ) patient , underwent single 240 minute HFR session . We study change IL-6 p-cresol circulating level , compare pre- post-HFR serum concentration . In addition , compare Il-6 p-cresol level UF enter ( UFin ) exiting ( UFout ) cartridge , either start end HFR session . The proinflammatory activity UFin UFout determine evaluate change induce IL-6 messenger ribonucleic acid ( mRNA ) expression release peripheral blood mononuclear cell ( PBMC ) collect 8 healthy volunteer culture vitro 24 hr .</brief_summary>
	<brief_title>HFR Cartridge Inflammation</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<criteria>HD patient undergo three weekly haemodialysis &gt; 1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>